×
About 7,994 results

ALLMedicine™ Prostate Biopsy Center

Research & Reviews  3,805 results

Systematic Biopsy of the Prostate can Be Omitted in Men with PIRADS 5 and PSA Density G...
https://doi.org/10.1097/JU.0000000000001766
The Journal of Urology; Tafuri A, Iwata A et. al.

Apr 5th, 2021 - To evaluate the prostate cancer (PCa) and clinically significant PCa (CSPCa) detection on systematic (SB), target biopsy (TB) alone and combined SB and TB in men with Prostate Imaging Reporting and Data System (PIRADS)-5 lesion. From a prospective...

Usefulness of Biparametric Magnetic Resonance Imaging Combined With Prostate Specific A...
https://doi.org/10.21873/anticanres.14992
Anticancer Research; Sekito S, Terabe T et. al.

Apr 4th, 2021 - The aim of this study was to identify simple and reliable factors to detect clinically insignificant prostate cancer (PC) for avoiding immediate prostate biopsies using biparametric magnetic resonance imaging (MRI), which consists of T2-weighted a...

The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Cli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025823
Current Oncology (Toronto, Ont.); Kato D, Ozawa K et. al.

Apr 3rd, 2021 - This study aimed to determine the predictive value of the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) based on biparametric magnetic resonance imaging (bpMRI) with combined target biopsy (TBx) and systematic biopsy (SBx) in p...

External validation and comparison of magnetic resonance imaging-based predictive model...
https://doi.org/10.1016/j.urolonc.2021.03.003
Urologic Oncology; Lee HJ, Lee A et. al.

Mar 29th, 2021 - Several multiparametric magnetic resonance imaging (mpMRI)-based models have been developed with significant improvements in diagnostic accuracy for clinically significant prostate cancer (csCaP), but lack proper external validation. We therefore ...

see more →

Guidelines  7 results

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline
http://www.auanet.org/guidelines/clinically-localized-prostate-cancer-new-(aua/astro/suo-guideline-2017)
Martin G. Sanda

Mar 31st, 2017 - These guidelines for the management of localized prostate cancer are structured first, to provide a clinical framework stratified by cancer severity to facilitate care decisions and second, to guide the specifics of implementing the selected manag.

Prostate MRI and MRI-Targeted Biopsy in Patients with Prior Negative Biopsy
http://www.auanet.org/guidelines/prostate-mri-and-mri-targeted-biopsy
Samir S. Taneja

Nov 30th, 2016 - While a large number of template prostate biopsies are performed annually in biopsy-naïve patients in the United States, a majority of the biopsy results are benign1, and a considerable fraction of tumors are missed2. Thus, the subsequent manageme.

The Prevention and Treatment of the More Common Complications Related to Prostate Biopsy Update
http://www.auanet.org/guidelines/prostate-needle-biopsy-complications
Michael A. Liss

Dec 31st, 2015 - Prostate cancer is the most common non-skin malignancy among men in the United States with nearly 250,000 new diagnoses each year. 1 Due to the United States Preventive Services Task Force recommendations in 2012, prostate biopsies may be decreasin.

Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follo...
https://academic.oup.com/annonc/article/26/suppl_5/v69/344382
Parker, C.

Jul 21st, 2015 - Subclinical prostate cancer is common in men >50 years of age. Population-based screening of men aged between 55 and 69 years, using prostate-specific antigen (PSA) testing, has been evaluated in randomised trials [1, 2].

Optimal Techniques of Prostate Biopsy and Specimen Handling
http://www.auanet.org/guidelines/prostate-biopsy-and-specimen-handling
Samir S. Taneja

Dec 31st, 2014 - An optimal prostate biopsy in clinical practice is based on a balance between adequate detection of clinically significant prostate cancers (sensitivity), assuredness regarding the accuracy of negative sampling (negative predictive value or NPV),.

see more →

Clinicaltrials.gov  4,013 results

Systematic Biopsy of the Prostate can Be Omitted in Men with PIRADS 5 and PSA Density G...
https://doi.org/10.1097/JU.0000000000001766
The Journal of Urology; Tafuri A, Iwata A et. al.

Apr 5th, 2021 - To evaluate the prostate cancer (PCa) and clinically significant PCa (CSPCa) detection on systematic (SB), target biopsy (TB) alone and combined SB and TB in men with Prostate Imaging Reporting and Data System (PIRADS)-5 lesion. From a prospective...

Usefulness of Biparametric Magnetic Resonance Imaging Combined With Prostate Specific A...
https://doi.org/10.21873/anticanres.14992
Anticancer Research; Sekito S, Terabe T et. al.

Apr 4th, 2021 - The aim of this study was to identify simple and reliable factors to detect clinically insignificant prostate cancer (PC) for avoiding immediate prostate biopsies using biparametric magnetic resonance imaging (MRI), which consists of T2-weighted a...

The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Cli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025823
Current Oncology (Toronto, Ont.); Kato D, Ozawa K et. al.

Apr 3rd, 2021 - This study aimed to determine the predictive value of the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) based on biparametric magnetic resonance imaging (bpMRI) with combined target biopsy (TBx) and systematic biopsy (SBx) in p...

External validation and comparison of magnetic resonance imaging-based predictive model...
https://doi.org/10.1016/j.urolonc.2021.03.003
Urologic Oncology; Lee HJ, Lee A et. al.

Mar 29th, 2021 - Several multiparametric magnetic resonance imaging (mpMRI)-based models have been developed with significant improvements in diagnostic accuracy for clinically significant prostate cancer (csCaP), but lack proper external validation. We therefore ...

see more →

News  169 results

Transient Drop in Erectile Function Seen After Prostate Biopsy
https://www.medscape.com/viewarticle/946042

Feb 18th, 2021 - NEW YORK (Reuters Health) - Undergoing prostate biopsy appears to lead to a brief reduction in erectile function which may resolve within months, although data are scarce and more study is needed, according to a new review and meta-analysis. Biops...

MRI-Guided Prostate Biopsy Prevails in PRECISE Trial
https://www.medscape.com/viewarticle/945398

Feb 4th, 2021 - Here's welcome news for men of a certain age: new results support a less invasive approach to investigations for suspicion of prostate cancer. An approach using MRI of the prostate followed by targeted biopsy (TB) in men with images suggesting a h...

Prostate Biopsy Need Not Substantially Delay Laser Enucleation
https://www.medscape.com/viewarticle/943224

Dec 27th, 2020 - NEW YORK (Reuters Health) - Holmium-laser enucleation of the prostate (HoLEP) to relieve bladder-outlet obstruction can be safely carried out within six weeks of transrectal ultrasound (TRUS)-guided prostate biopsy, according to a retrospective re...

Combined MRI and Ultrasound Prostate Biopsy: 'Paradigm Shift'
https://www.medscape.com/viewarticle/926547

Mar 9th, 2020 - Combining MRI-guided biopsy of the prostate with conventional ultrasound-guided 12-core prostate biopsy was superior to either technique alone at ruling out more aggressive cancers, and beat MRI-guided biopsy alone at detecting clinically signific...

Could a 'Manogram' Replace a Prostate Biopsy?
https://www.staging.medscape.com/viewarticle/916297

Jul 31st, 2019 - Could imaging replace a painful biopsy in testing for prostate cancer? Such is the vision of Jelle Barentsz, MD, PhD, from the Radboud University Medical Center in Nijmegen, the Netherlands, who recently presented data to support the use of a fast...

see more →